Phenotype measures set:   McMullan6   fat_end

ID, description, units MPD:61521   fat_end   percentage of body mass that is fat after 4 wks of treatment   [%]
exercise study
Measures • no exercise group    • moderate intensity group    • high intensity group
Data set, strains McMullan6   CC   4 strains     sex: both     age: 8-10wks
Procedure MRI
Comparisoncontrol group vs. multiple treatment / dosage groups
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

McMullan6 - percentage of body mass that is fat after 4 wks of treatment





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 2 129.1 64.55 6.9583 0.0012
sex 1 39.1218 39.1218 4.2172 0.0412
strain 3 2315.3492 771.7831 83.1956 < 0.0001
group:sex 2 114.7874 57.3937 6.1868 0.0024
group:strain 6 263.6868 43.9478 4.7374 0.0001
sex:strain 3 233.1064 77.7021 8.376 < 0.0001
group:sex:strain 6 117.7157 19.6193 2.1149 0.0528
Residuals 214 1985.2212 9.2767

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
McMullan6 61521 MRI exercise percentage of body mass that is fat after 4 wks of treatment   [%]   no exercise group   fat_end_ctrl CC 4 both 8-10wks
McMullan6 61522 MRI exercise percentage of body mass that is fat after 4 wks of treatment   [%]   moderate intensity group   fat_end_MICT CC 4 both 8-10wks
McMullan6 61523 MRI exercise percentage of body mass that is fat after 4 wks of treatment   [%]   high intensity group   fat_end_HIIT CC 4 both 8-10wks